Docking analysis and resistance evaluation of clinically relevant mutations associated with the HIV-1 non-nucleoside reverse transcriptase inhibitors nevirapine, efavirenz and etravirine.
about
Molecular mechanism of antagonism between the Y181C and E138K mutations in HIV-1 reverse transcriptaseIn vitro characterization of MK-1439, a novel HIV-1 nonnucleoside reverse transcriptase inhibitor.A novel vaginal microbicide containing the rationally designed anti-HIV compound HI-443 (N'-[2-(2-thiophene)ethyl]-N'-[2-(5-bromopyridyl)] thiourea]).Hepatitis C virus genetic variability and the presence of NS5B resistance-associated mutations as natural polymorphisms in selected genotypes could affect the response to NS5B inhibitors.In vitro resistance selection with doravirine (MK-1439), a novel nonnucleoside reverse transcriptase inhibitor with distinct mutation development pathways.Non-nucleoside reverse transcriptase inhibitor (NNRTI) cross-resistance: implications for preclinical evaluation of novel NNRTIs and clinical genotypic resistance testing.KRDS: a web server for evaluating drug resistance mutations in kinases by molecular docking.Monotypic low-level HIV viremias during ART are associated with disproportionate production of X4 virions and systemic immune activation.
P2860
Q36397384-B10938E6-B5E9-42C8-B2BA-C2221ED72EF9Q37643598-B2ACB7AE-7763-4E94-97BB-ECE7CD14A26EQ37980177-E2F65392-8229-4922-AC31-0D49AE565429Q38849307-C0F5E324-2158-4DB2-AECE-AA652463C8F7Q41668874-DA56E6BE-5134-44E3-9AB5-EBED5546C70FQ42101552-F701787E-6C8F-4488-AE0E-5A4BD15B7C12Q52597351-7B420BE2-6745-4FB5-AB6E-E45CC8BC71ACQ54230375-019C1B7E-5983-418B-995C-5546CA31D5C0
P2860
Docking analysis and resistance evaluation of clinically relevant mutations associated with the HIV-1 non-nucleoside reverse transcriptase inhibitors nevirapine, efavirenz and etravirine.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
Docking analysis and resistanc ...... ine, efavirenz and etravirine.
@en
Docking analysis and resistanc ...... ine, efavirenz and etravirine.
@nl
type
label
Docking analysis and resistanc ...... ine, efavirenz and etravirine.
@en
Docking analysis and resistanc ...... ine, efavirenz and etravirine.
@nl
prefLabel
Docking analysis and resistanc ...... ine, efavirenz and etravirine.
@en
Docking analysis and resistanc ...... ine, efavirenz and etravirine.
@nl
P2093
P2860
P50
P356
P1433
P1476
Docking analysis and resistanc ...... ine, efavirenz and etravirine.
@en
P2093
Anna Artese
Bernard Masquelier
Lucia Parrotta
Tobias Sing
Valentina Svicher
Vincent Calvez
P2860
P304
P356
10.1002/CMDC.201100362
P50
P577
2011-09-27T00:00:00Z